FOXN3 and acute myeloid leukemia: However, it seems that the prognostic effect of FOXN3 expression was inconsistent with the public data from the Cancer Genome Atlas (TCGA) (http://www.cbioportal.org)7, 32 and Beat AML database (http://www.vizome.org)33 even if APLs were removed (Figure S3).